¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"phase II trial"¿¡ ´ëÇÑ ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
À̰ÍÀ» ¿øÇϼ̽À´Ï±î?
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
phase II trial A study to test whether a new treatment has an anticancer effect (for example, whether it shrinks a tumor or improves blood test results) and whether it works against a certain type of cancer.
Ãâó: www.stjude.org/glossary
phase II trial The second stage in testing a new drug in humans. Performed in patients with the disease or condition being studied. The main purpose is to evaluate the activity of a drug, and to possibly provide information on how well the drug works.
Ãâó: www.aegis.com/pubs/cria/2003/CR030902.html
phase II trial Clinical trial conducted to test how well a new cancer treatment works against a certain type of cancer.
Ãâó: www.melanomacenter.org/glossary/p.html
phase II trial Study of a group of similar patients to determine whether there is a statistical likelihood that a new treatment will be effective against a tumor.
Ãâó: dfw-neuronetwork.com/Glossary.htm
phase II trial A study designed to get more information about a new drug's safety and how effective the drug may be. These trials may include 20-40 patients over a couple of years. A higher level of response must be seen to move the drug into phase III trials (see below).
Ãâó: saci.uthscsa.edu/PatientServices/glossary.html
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á